학술논문
PRM174 - Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial: Equating the Msis-29, Msws-12, Abilhand-56 and Sf-36
Document Type
Abstract
Author
Source
In Value in Health November 2015 18(7):A713-A713
Subject
Language
ISSN
1098-3015